Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions

Microbiology and Immunology

Volumn 46, Issue 11, 2002, Pages 741-749

  Hamamoto, Kumiko ^a   Kida, Yutaka ^a   Zhang, Ye ^a   Shimizu, Takashi ^a   Kuwano, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial peptide; Cationic peptide; D amino acids

Indexed keywords

ARGININE; ARGINYLVALYLCYSTEINYLARGINYLTHREONYLGLYCYLARGINYLSERYLARGINYLTRYPTOPHYLARGI NINE; GRANULYSIN; PEPTIDE; PROTEINASE INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIOLYSIS; BACTERIUM CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; FETAL CALF SERUM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEINASE INHIBITION; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0036445391     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02759.x     Document Type: Article

References (31)

1. Aderem, A., and Ulevitch, R.J. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406: 782-787.
2. Andersson, M., Girard, R., and Cazenave, P.-A. 1999. Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin. Infect. Immun. 67: 201-205.
3. Andersson, M., Gunne, H., Agerberth, B., Boman, A., Bergman, T., Sillard, R., Jornvall, H., Mutt, V., Olsson, B., Wigzell, H., Dagerlind, A., Boman, H.G., and Gudmundsson, G.H. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells. Structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 14: 1615-1625.
4. Andreu, D., Carreno, C., Linde, C., Boman., H.G., and Andersson, M. 1999. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344: 845-849.
5. Bessalle, R., Kapitkovsky, A., Gorea, A., Shalit, I., and Fridkin, M. 1990. All-D-magainin: Chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274: 151-155.
6. th Ed, Prentice-Hall, Englewood Cliffs, N.J.
7. Chia, B.C., Carver, J.A., Mulhern, T.D., and Bowie, J.H. 2000. Maculatin 1.1, an anti-microbial peptide from the Australian tree frog, Litoria genimaculata solution structure and biological activity. Eur. J. Biochem. 267: 1894-1908.
8. Chia, C.S.B., Torres, J., Cooper, M.A., Arkin, I.T., and Bowie, J.H. 2002. The orientation of the antibiotic peptide maculatin 1.1 in DMPG and DMPC lipid bilayers. Support for a pore-forming mechanism. FEBS Lett. 512: 47-51.
9. Dankesreiter, S., Hoess, A., Schneider-Mergener, J., Wagner, H., and Miethke, T. 2000. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J. Immunol. 164: 4804-4811.
10. Darveau, R.P., Cunningham, M.D., Seachord, C.L., Cassiano-Clough, L., Cosand, W.L., Blake, J., and Watkins, C.S. 1991. β-lactum antibiotics potentiate Magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob. Agents Chemother. 35: 1153-1159.
11. Ernst, W.A., Thoma-Uszynski, S., Teitelbaum, R., Ko, C., Hanson, D.A., Clayberger, C., Krensky, A.M., Leippe, M., Bloom, B.R., Ganz, T., and Modlin, R.L. 2000. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165: 7102-7108.
12. Falo, L.D., Jr., Colarusso, L.J., Benacerraf, B., and Rock, K.L. 1992. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. U.S.A. 89: 8347-8350.
13. Fernandez-Lopez, S., Kim, H.-S., Choi, E.C., Delgado, M., Granja, J.R., Khasanov, A., Kraehenbuehl, K., Long, G., Weinberger, D.A., Wilcoxen, K.M., and Ghadiri, M.R. 2001. Antibacterial agents based on the cyclic D,L-α-peptide architecture. Nature 412: 452-455.
14. Hancock, R.E.W. 1997. Peptide antibiotics. Lancet 349: 418-422.
15. Hancock, R.E.W., and Chapple, D.S. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43: 1317-1323.
16. Hirata, M., Yoshida, M., Inada, K., and Kirikae, T. 1990. Investigation of endotoxin binding cationic proteins from granulocytes; agglutination of erythrocytes sensitized with RE-LPS. Adv. Exp. Med. Biol. 256: 287-299.
17. Hong, S.Y., Oh, J.E., and Lee, K.-H. 1999. Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide. Biochem. Pharmacol. 58: 1775-1780.
18. Kirikae, T., Hirata, M., Yamasu, H., Kirikae, F., Tamura, H., Kayama, F., Nakatsuka, K., Yokochi, T., and Nakano, M. 1998. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66: 1861-1868.
19. Larrick, J.W., Hirata, M., Balint, R.F., Lee, J., Zhong, J., and Wright, S.C. 1995. Human CAP18: A novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63: 1291-1297.
20. Larrick, J.W., Morgan, J.G., Palings, I., Hirata, M., and Yen, M.H. 1991. Complementary DNA sequence of rabbit CAP18-a unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179: 170-175.
21. Pena, S.V., Hanson, D.A., Carr, B.A., Goralski, T.J., and Krensky, A.M. 1997. Processing, subcellular localization, and function of 519 (Granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158:2680-2688.
22. Piers, K.L., Brown, M.H., and Hancock, R.E.W. 1994. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob. Agents Chemother. 38: 2311-2316.
23. Poltorak, A., He, X., and Smirnova, I. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutation in Tlr4 gene. Science 282: 2085-2088.
24. Scott, M.G., Gold, M.R., and Hancock, R.E.W. 1999. Interaction of cationic peptides with lipoteichoic acid and Gram-positive bacteria. Infect. Immun. 67: 6445-6453.
25. Scott, M.G., Vreugdenhil, A.C.E., Buurman, W.A., Hancock, R.E.W., and Gold, M.R. 2000. Cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J. Immunol. 164: 549-553.
26. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462: 55-70.
27. Stenger, S., Hanson, D.A., Teitelbaum, R., Dewan, P., Niazi, K.R., Froelich, C.J., Ganz, T., Thoma-Uszynski, S., Melian, A., Bogdan, C., Porcelli, S.A., Bloom, B.R., Krensky, A.M., and Modlin, R.L. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282: 121-125.
28. Wang, Z., Choice, E., Kaspar, A., Hanson, D., Okada, S., Lyu, S.-C., Krensky, A.M., and Clayberger, C. 2000. Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin. J. Immunol. 165: 1486-1490.
29. Wu, M., and Hancock, R.E.W. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274: 29-35.
30. Yabe, T., McSherry, C., Bach, F.H., and Houchins, J.P. 1990. A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein. J. Exp. Med. 172: 1159-1163.
31. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415: 389-395.